Introduction
A fter liver injury, normally quiescent hepatocytes are capable of self-renewal by entering the cell cycle until restoring the liver parenchyma and initial functions. However, when the liver is subjected to severe or chronic injury, hepatocytedriven liver regeneration is altered or insufficient, and an alternative regenerative process involving the liver progenitor cell (LPC) compartment is then engaged. (1) In virtually all human liver diseases, LPC proliferation is frequently observed within proliferative ductular cells and is referred to as ductular reaction (DR), with an important histologic and mechanistic heterogeneity. (2, 3) DR is defined as the proliferation of apparent ductules that accompany leukocyte infiltration in response to liver injury. (4) In humans, the expansion of biliary-like cells or LPCs is associated with severity of chronic liver disease, regardless of the etiology. (5) (6) (7) While LPCs are reported as key cells promoting liver Abbreviations: Alb, albumin; BMOL, bipotential murine oval liver; CDE, choline-deficient and ethionine-supplemented; CK19, cytokeratin 19; DR, ductular reaction; HNF, hepatocyte nuclear factor; IL, interleukin; LPC, liver progenitor cell; Mcp1, monocyte chemoattractant protein 1; MELD, Model for End-Stage Liver Disease; mRNA, messenger RNA; TAT, tyrosine aminotransferase; Th, T helper; TNF, tumor necrosis factor; WSX-1, interleukin-27 receptor, alpha subunit; WT, wild-type.
regeneration, in certain circumstances their presence is also correlated with progressive fibrogenesis (8, 9) and could contribute to hepatocellular carcinoma initiation. (10) Therefore, determination of the mechanisms leading to LPC activation and controlling their expansion represent a key step in understanding liver pathogenesis development and may help to propose novel therapeutic strategies.
The origin of LPCs is still subject to debate. However, most recent publications converge toward the likelihood of LPC emergence from a stem/progenitor cell niche located in the portal region around the canals of Hering. LPCs can differentiate toward functional hepatocytes and mature cholangiocytes in vitro. Numerous murine lineage-tracing models have suggested that LPCs do not contribute to hepatocyte regeneration in several experimental models of liver injury, including 2/3 partial hepatectomy, bile duct ligation, carbon tetrachloride intoxication, and a 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet. However, after severe hepatocyte loss, biliary-like or liver progenitor cells can differentiate toward functional hepatocytes and mature cholangiocytes in vivo in zebrafish and in mouse models. (11) (12) (13) Furthermore, in another murine model using a choline-deficient and ethioninesupplemented diet (CDE), Español-Suñer et al. (14) and Rodrigo-Torres et al. (15) found that LPCs contribute to hepatic regeneration with up to 2% of newly generated hepatocytes arising from LPCs. It has recently been demonstrated that differentiated cells from such progenitors yield functional hepatocytes characterized by hepatocyte-specific marker expressions, such as hepatocyte nuclear factor (HNF)4a. (16) A contribution of LPCs to the restoration of the parenchymal architecture and liver function has been assumed in humans, and a recent study reported long-term expansion of LPCs from human liver and their conversion into functional hepatocytes in vitro and with transplantation in vivo. (17) Activation of the LPC compartment is a complex process that is not fully understood. The LPC response can be divided into four steps: activation, proliferation, migration, and differentiation. (18) The induction and progression of the LPC-driven regenerative process is highly influenced by the microenvironment and the cytokines released by immune cells during inflammation. (19) For instance, a recent study reported the association between portal inflammation and DR in nonalcoholic fatty liver disease. (20) Both innate and adaptive immune cells recruited during the inflammatory process are critical for the modulation of LPCdriven liver regeneration, as demonstrated by numerous studies using the CDE model. Van Hul et al. (21) have reported that macrophage depletion by clodronate injections attenuates fibrogenesis and LPC parenchymal invasion. Furthermore, it has been shown that in mice lacking T cells, the LPC response was drastically weakened and mice succumbed to acute liver failure. (22) The LPC compartment is also highly activated during T-cell-mediated hepatitis induced by concanavalin A. (23) Numerous cytokines constitute key links between inflammation and LPC proliferation, such as tumor necrosis factor (TNF)-a, TNF-like weak inducer of apoptosis (TWEAK), interferon-gamma (IFN-c), interleukin-6 (IL-6), IL-22, and lymphotoxin b. (24) (25) (26) (27) (28) Among the key players in modulating liver inflammation, T helper (Th)17 lymphocytes have been implicated in several types of liver diseases through the effects of IL-17A (IL-17) and IL-22. (29, 30) While IL-22 has been reported as hepatoprotective, (31) antifibrotic, (32) and promoting liver regeneration from LPCs, (28) the potential role of IL-17, notably in regeneration, has not been fully investigated. IL-17 is a proinflammatory cytokine known to contribute to the crosstalk between innate and adaptive immunity. Recently, we and others reported direct and indirect profibrogenic and proinflammatory effects of IL-17 by stimulating both myofibroblasts and macrophages. (33, 34) Furthermore, it has been shown that IL-17-producing gamma delta T (cdT) cells were recruited during hepatocyte-driven liver regeneration induced by partial hepatectomy. (35) The authors showed that IL-17-induced IL-6 production by macrophages and dendritic cells, favored hepatocyte proliferation, and could also be involved in LPC-driven liver regeneration. To achieve hepatic regeneration from LPCs, those cells need to proliferate but also to undergo cell differentiation into mature cells. Interestingly, several groups demonstrated that IL-27, a cytokine mainly produced by macrophages, has been shown to directly favor stem/progenitor cell differentiation in different organs. (36) (37) (38) (39) IL-27 is a pleiotropic cytokine belonging to the IL-12 family that signals through its heterodimeric receptor composed of gp130 and IL-27 receptor alpha (WSX-1) subunits, mainly expressed by immune and epithelial cells, including hepatocytes. (40) We therefore hypothesized that communication between adaptive and innate immune cells through IL-17 and IL-27 production, respectively, could contribute to the achievement of liver regeneration from LPCs.
In biopsies obtained from patients with various types of liver diseases, IL-17 1 cells were identified in close association with liver ductular cells, and their infiltration positively correlated with the degree of DR in our study. To address the role of IL-17 and IL-27 in LPC activation, proliferation, and differentiation into mature hepatocytes, IL-17-deficient (IL-17
2/2
) and WSX-1-deficient (WSX-1 2/2 ) mice were fed a CDE diet, and murine liver progenitor cells were used. Our results showed complementary roles of IL-17 and IL-27 in achieving the regenerative process of the liver by inducing LPC proliferation and by favoring differentiation, respectively.
Materials and Methods

HUMAN SAMPLES
Forty-three liver samples from patients with diverse chronic liver diseases were analyzed. The study conformed to the ethical guidelines of the 1975 Declaration of Helsinki. As required by French legislation, the study was approved by the local ethics committee Ile de France I (Institutional Review Board 2017-A01215-48). Blocks of formalin-fixed paraffin-embedded samples from explanted livers were obtained from the Department of Pathology of Henri Mondor University Hospital (Creteil, France). For the assessment of cytokeratin 19 (CK19)
1 and IL-17 1 cell density, a training set of 20 slides was first reviewed by two evaluators, including a pathologist specialized in liver diseases. The whole cohort was then analyzed independently by the two evaluators using a semiquantitative score, and patients were dichotomized into high versus low density of stained cells for each labeling.
ANIMALS
We used 6-8-week-old male mice on a C57BL/6 background in this study. IL-17 2/2 mice were generously provided by Professor Yoichiro Iwakura (Japan). WSX-1 2/2 mice were purchased from the Jackson Laboratory. Mice were fed a control (choline-sufficient) or choline-deficient diet (MP Biomedicals, Illkirch, France), and drinking water was supplemented with DLethionine (0.15% weight/volume) (Sigma-Aldrich, Lyon, France) in the CDE-fed group. Animals were killed at indicated time points, blood was collected for serum extraction, and the liver was either fixed in buffered formalin or snap frozen in liquid nitrogen. Experiments were performed on at least four animals per group and per time point. All animals were housed and fed ad libitum in a pathogen-free animal facility and used in accordance with protocols approved by the French ethical committee (COMETH, Authorization N812-079) and under the supervision of authorized investigators.
STATISTICAL ANALYSIS
Results are expressed as mean 6 SEM, and statistical significance was determined by a two-tailed Student t test or one-or two-way analysis of variance as appropriate, using PRISM 4.0 software. Data were considered significantly different for P < 0.05. Contingency between CK19 and IL-17 staining and Model for End-Stage Liver Disease (MELD) scores were assessed by Fisher's exact test and Child-Pugh scores by the chi-square test.
Results
DR CORRELATES WITH IL-17-PRODUCING CELL INFILTRATION IN HUMAN DISEASED LIVERS
DR with LPCs is frequently observed in several types of liver diseases and is often associated with the inflammatory process. (3, 20) In addition, IL-17 1 cells were found in the livers of patients with chronic liver diseases. (29, 30) To determine whether the proliferative LPCs correlate with the number of infiltrating IL-17-producing cells, a cohort of 43 patients with chronic liver diseases from various etiologies was analyzed. Most of the patients presented with mild inflammatory activity (86.1%, METAVIR score A1-A2) with severe fibrosis (93.0% METAVIR F4) (Supporting Table S1 ). On paraffin-embedded liver tissues from these patients, we revealed an infiltration of IL-17-producing cells surrounding CK19
1 LPCs with a close interaction, regardless of the etiology (Fig. 1) . A score was defined semiquantitatively, and patients were classified into two groups with a low and high degree of DR ( Fig. 2A) . Similarly, IL-17 1 cells infiltrating the livers were scored and classified into two groups with a low and high degree of IL-17-expressing cells. A positive correlation was found between the densities of these two cell types (P < 0.001) (Fig. 2B) , with a majority of CK19 high patients having a high density of infiltrating IL-17 1 cells in the liver. In addition, patients with low CK19 and IL-17 scores were predominantly Child-Pugh class A with a MELD score 15, whereas most patients who were CK19
high IL-17 high were Child-Pugh class B or C with a MELD score >15 ( Fig. 2C,D ; Supporting Table S1 ). Collectively, these data showed that increased IL-17 1 cell infiltration is associated with CK19
1 LPC accumulation in human DR and with a less optimistic prognosis. These clinical observations led us to hypothesize that IL-17 could promote LPC accumulation in diseased livers.
DISRUPTION OF THE IL-17 GENE IMPAIRS LPC ACTIVATION IN REGENERATING LIVER
To determine the role of IL-17 in LPCcompartment activation in regenerating livers, wild- 
type (WT) and IL-17
2/2 mice were subjected to the CDE diet for 3, 10, or 21 days. In this model, expression of several inflammatory genes inducing Th17 cell differentiation (IL-6, transforming growth factor b) and specific markers, including IL-23 receptor (IL-23R) and retinoic acid receptor-related orphan receptor alpha (ROR-a) but not RORct, were up-regulated as early as 3 days and were maintained along with the diet in WT animals (Supporting Fig. S1 ). LPC accumulation was evaluated on liver tissue sections of both WT and IL-17 2/2 CDE-fed mice with CK19 immunostaining (Fig. 3A) . WT mice showed a significant increase in CK19 1 cells from day 3, with a progressive accumulation along with the CDE diet. In contrast, IL-17 deficiency was sufficient to significantly prevent LPC accumulation as early as 3 days after the CDE diet (Fig. 3A) . This result has been confirmed in another model of DR in a cholestatic environment induced by bile duct ligation and section (Supporting Fig. S2 ). Along the same line of evidence, messenger RNA (mRNA) expression of LPC response-associated markers (alpha-fetoprotein [AFP], M2-pyruvate kinase), with the exception of the hematopoietic Thy-1 cell surface antigen (Thy1) marker, were induced in the liver from WT mice in the CDE model, reaching a peak at day 3; such inductions were markedly reduced in IL-17 2/2 mice (Fig. 3B) . Double-stained CK19
1 Ki67 1 cells revealed proliferative LPCs reaching 15% of the total CK19 1 counted cells in WT mice, whereas no proliferating LPCs were detected in IL-17 2/2 mice after 21 days of the CDE diet (Fig.  3C,D) . This reduced-LPC activation in IL-17 2/2 mice was not attributable to a difference in liver injury as serum transaminases (alanine aminotransferase, aspartate aminotransferase) and alkaline phosphatase activities were similarly increased in WT and IL-17 2/ 2 animals at earlier time points (Fig. 3E) . No difference was observed on histologic analysis on hematoxylin and eosin-stained liver tissue sections (Supporting Fig. S3 ). In addition, food intake was assessed in both groups and did not show any difference (Supporting Fig. S4 ). Finally, despite a slight increase in fibrogenesis-related gene expressions in livers of WT CDE-fed mice, no obvious increase in sirius red staining was observed in those mice (Supporting Fig. S5A-C) . Taken together, these data showed that IL-17 deficiency is associated with reduced LPC accumulation. 
IL-17 DEFICIENCY REPRESSES LIVER INFLAMMATION, INCLUDING IL-27 PRODUCTION
It is well established that the liver inflammatory response triggered by macrophage recruitment and activation tightly controls LPC expansion. To further determine whether defective LPC accumulation, identified in IL-17 2/2 animals, could result from the reduced liver inflammatory response, we evaluated macrophage recruitment and the expression of their secreted inflammatory mediators. While monocyte chemoattractant protein 1 (Mcp1) and F4/80 mRNA expressions were induced with a peak reached at 3 days in WT, such induction was not observed in IL-17 2/2 mice (Fig. 4A) . Furthermore, F4/80 immunostaining in WT mice showed a 3-fold increase in macrophage cell numbers infiltrating the livers 3 days after the CDE diet; such infiltration was significantly lower in IL-17 2/2 mice (Fig. 4B) . Expressions of several macrophage-associated inflammatory cytokines were also assessed; in WT animals under the CDE diet, the 
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data revealed an up-regulated hepatic expression of Tnfa, Il6, and of Epstein-Barr virus-induced 3 (Ebi3) and Il27p28, two subunits constituting the heterodimeric IL-27 cytokine (Fig. 4C) . In contrast, the expressions of those genes were not up-regulated in mice lacking IL-17 expression (Fig. 4C ). In addition, treatment of RAW264.7 macrophages with recombinant IL-17 significantly induced proinflammatory chemokine/cytokine mRNA expressions, including Mcp1, Tnfa, Il6, and Ebi3 and Il27p28 (Fig. 4D) . Altogether, these data showed a key role of IL-17 in triggering the well-described hepatic inflammatory response necessary for LPC activation (e.g., Mcp1, Tnfa, Il6) and revealed an induced expression of IL-27 with a putative role in LPC-driven liver regeneration.
WSX-1 DEFICIENCY REPRESSES LPC-DRIVEN LIVER REGENERATION
IL-27 is a cytokine with a well-known modulatory function in progenitor cell-mediated tissue repair in other organs. (41, 42) To address the potential role of the IL-27-WSX-1 axis in LPC accumulation, WT and WSX-1 2/2 mice were subjected to CDE-diet feeding. CK19 immunostaining on liver tissue sections showed a strong inhibition of LPC accumulation in WSX-1 2/2 animals when compared with their WT counterpart from day 3 after the CDE diet (Fig. 5A ). In agreement with these CK19 immunostaining data, mRNA expressions of LPC activation-related genes (Afp, Thy1) were not induced in WSX-1 2/2 mice (Fig.  5B) . Interestingly, proliferating CK19
1 cells identified by CK19 and Ki67 double staining revealed that 12% of CK19 1 LPCs were proliferating 21 days after the CDE diet in WT mice, while only 2.5% of proliferating CK19 1 cells were counted in WSX-1 2/2 mice (Fig. 5C,D) . This strongly suggests an essential involvement of the IL-27-WSX-1 axis in the LPC activation process.
CDE DIET-INDUCED LIVER INFLAMMATION IS REDUCED IN WSX-1 2/2 MICE
A disrupted IL-27 signaling pathway is associated with reduced LPC accumulation after a CDE diet. To better characterize the mechanisms that could explain this observation, we evaluated liver injury and inflammation. Serum transaminases and hematoxylin and eosin staining on liver tissue sections showed similar S6A and S4B ). In addition, food intake was assessed in both types of mice and did not show any difference (Supporting Fig. S6C ). Liver macrophages infiltrating the liver after the CDE diet were quantified in WT and WSX-1 2/2 mice. Mcp1 and F4/80 mRNA expressions were significantly induced and peaked 3 days after the CDE diet in WT animals but not in WSX-1 2/2 mice (Fig. 6A ). In addition, F4/80 immunostaining of liver samples confirmed a 3-fold increase in the number of macrophages infiltrating the livers of CDE-treated WT mice, but such increase was completely abolished in livers of CDE-treated WSX-1 2/2 animals (Fig. 6B) . Analysis of inflammatory cytokines revealed an increase in mRNA expression of Tnfa, Il6, Ebi3, and Il27p28 in WT mice but not in WSX-1 2/2 animals. Moreover, IL-27-treated RAW cells showed increased Il6, Tnfa, and Ebi3 but not Il27p28 mRNA expressions (Fig. 6D) . Lastly, CDEinduced Th1, Th2, and Th17 marker gene expressions were significantly lowered in WSX-1 2/2 compared to WT mice (Supporting Fig. S7 ). This strongly suggests that the IL-27-WSX-1 axis is required to promote the inflammatory response required for supporting the LPC compartment.
IL-17 FAVORS LPC PROLIFERATION WHEREAS IL-27 INDUCES EXPRESSION OF HEPATOCYTE DIFFERENTIATION MARKERS
As LPC accumulation was strongly altered in both IL-17 2/2 and IL-27 2/2 animals under the CDE diet, we further deciphered the direct role of IL-17 and IL-27 on LPCs in vitro. Bipotential murine oval liver (BMOL) cells, a well characterized LPC cell line, were cultured in the absence or presence of either IL-27 or IL-17. Cell viability and proliferation were evaluated by the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay and showed that IL-17 potentiated BMOL cell growth along with a 5-day culture while IL-27 had no effect (Fig. 7A) . To evaluate the potent role of IL-17 and IL-27 in LPC differentiation, hepatocytic cell differentiation marker mRNA expressions, including albumin (Alb), tyrosine aminotransferase (Tat), and Hnf4a were also assessed (Fig. 7B) . Our data revealed that IL-17 did not increase but instead decreased some of those markers, including Alb and Tat expressions. In contrast, BMOL treatment with IL-27 increased Alb and Hnf4a mRNA expressions (Fig. 7B) . Similarly, hepatocytic cell markers analyzed at protein levels by western blot showed an increased expression of Alb, TAT, and HNF4a in the presence of IL-27 (Fig.  7C,D) . IL-27 did not potentiate the effects of the hepatocyte-differentiation culture medium (Supporting Fig. S8 ). However, IL-17 treatment in similar conditions reduced hepatocytic differentiating markers consistently with results obtained in normal culture conditions (Fig. 7B) . To confirm the putative role of IL-27 in differentiating LPCs into hepatocytes, freshly isolated LPCs from mouse livers after a 21-day CDE diet were cultured in the absence or presence of IL-27 or IL-17. The purity of freshly isolated LPCs was assessed by flow cytometry and showed 94.8% epithelial cell adhesion molecule (EpCAM) 1 CD45 -isolated cells (Supporting Fig. S9 ). IL-27 treatment strongly induced Alb, Tat, and Hnf4a mRNA expressions when compared to nontreated controls. IL-17 treatment did not induce any of those hepatocytic markers but diminished Hnf4a mRNA expression (Fig. 7E) . Similarly, HNF4a immunostaining on freshly isolated LPCs showed a weak basal level in control cells (Fig. 7F) while IL-27 treatment significantly induced HNF4a expression. In contrast, IL-17 treatment completely abolished HNF4a expression. Compared to BMOL cells that have been immortalized, freshly isolated LPCs do not show significant proliferation in vitro in our basal culture conditions. Therefore, no significant effect of IL-17 or IL-27 treatment was obtained on proliferation assays (data not shown). Taken together, these data demonstrate a direct role of IL-17 in mediating LPC accumulation while IL-27 plays a complementary role by favoring LPC differentiation toward a hepatocytic phenotype.
Discussion
A large spectrum of growth factors and cytokines has been reported to contribute to LPC niche activation, and some of these have been described as dispensable due to redundant functions. In the present study, we report a correlation between IL-17-producing cell recruitment and the severity of the DR, and we identify IL-17 as a cytokine with a central role in triggering LPC compartment activation and proliferation. We also reveal that IL-17 is responsible for macrophage-induced IL-27 expression that favors LPC differentiation into hepatocytes. We therefore highlight collaborative work between IL-17 and IL-27 that is required to properly achieve liver regeneration from progenitor cells (Fig. 8) .
ASSOCIATION OF DR WITH INFLAMMATORY CELLS
In virtually all types of chronic liver diseases, biliary and liver progenitor cell accumulation, referred to as DR, is frequently observed. (3) In humans, LPC accumulation is an important prognostic marker in advanced liver diseases and is often associated with a less optimistic outcome. (43) In our study, comparison of CK19 low with CK19 high groups of patients revealed a higher Child-Pugh and MELD score severity associated with increased LPC expansion. DR is accompanied by recruitment of immune cells nearby, and compelling findings in both animal and human studies emphasize the pivotal role of inflammatory cytokines in the LPC-driven regenerative process. (19, 20, (23) (24) (25) FIG. 7. IL-17 favors LPC proliferation whereas IL-27 induces their differentiation. BMOL cells were treated with 50 ng/mL recombinant IL-27 or IL-17, and (A) proliferation was assessed by optical density using an MTS assay. Hepatocyte differentiation marker expression was analyzed by (B) qRT-PCR after 6 hours or (C) by western blot after 24 hours of treatment. (D) Western blot quantification (n 5 6-8 independent experiments). Results are expressed as fold change over untreated cells. *P < 0.05, **P < 0.01, ***P < 0.005. (D,E) Primary LPCs were cultured in the presence of 50 ng/mL recombinant IL-17 or IL-27 for 24 hours. Hepatocyte differentiation marker expressions were analyzed by (E) qRT-PCR and (F) immunocytochemistry using an anti-HNF4a antibody. 
IL-17 IN LPC ACTIVATION AND PROLIFERATION
Based on the clinical study of chronic liver diseases, regardless of etiology, we report a positive correlation between the degree of DR and the number of IL-17-producing cells infiltrating the liver. The proximity between IL-17 1 cells and LPCs led us to hypothesize that IL-17 could be associated with LPC activation and proliferation. Moreover, increased IL-17 1 cells infiltrating the liver of CK19 high patients aggravate their Child-Pugh and MELD scores (Supporting Table S1 ). Mixed phenotypes CK19 high IL-17 low and CK19 low IL-17 high were found in few patients. The source of IL-17-producing cells reported in human livers is heterogeneous and mainly includes Th17 lymphocytes, cd T cells, and neutrophils. (20, 29, 30, 33) In mouse, we cannot exclude a different profiling of IL-17-producing cell types, depending on the experimental model, when compared to human liver diseases. However, in the murine model of CDE-diet-induced liver regeneration from LPCs, we revealed an induced expression of Th17-associated genes as early as 3 days after a CDE diet in WT animals. Such induced expressions were maintained along with the protocol (Supporting Fig. S1 ), although IL-17 levels in the serum or liver were not detectable by using currently available kits (data not shown). In keeping with results obtained in a previous work, (22) our data strongly support the participation of Th17 cells in the hepatic production of IL-17. Interestingly, we showed that in mice lacking IL-17 expression and subjected to a CDE diet, the capacity of LPCs to accumulate is dramatically altered when compared to WT animals. Along the same lines of evidence, LPC treatment with IL-17 promoted LPC expansion in vitro. Furthermore, we previously reported a role of IL-17 in polarizing macrophages toward a proinflammatory M1 phenotype. (34) In this study, we show that IL-17 deficiency causes impairment of macrophage cell recruitment in CDE-diet-induced liver regeneration, resulting in reduced hepatic inflammation. This reduced inflammatory response may explain the reduced liver injury observed at later time points in IL-17 2/2 animals. These results are consistent with previous reports showing that macrophage depletion by clodronate injections abrogates LPC accumulation and subsequent liver regeneration during a CDE diet. (21) The results obtained in vivo clearly provide evidence that IL-17 deficiency alters LPC expansion, which fits with in vitro data. However, neither IL-17 deficiency (Fig. 3A) nor macrophage depletion (44) were sufficient to completely abolish DR. This suggests that IL-17 could contribute to LPC expansion by i) directly promoting LPC proliferation and ii) indirectly through M1-macrophage-induced production of required factors, e.g., TNF-a and IL-6, which support LPC accumulation. (19, 45) IL-17 has been detected in several types of chronic liver diseases (29, 30) and was associated with increased liver injury and fibrosis (33, 34) and hepatocellular carcinoma. (46, 47) Our data highlight that a sustained IL-17 inflammatory response lacking a differentiating process may be responsible for incomplete hepatic regeneration, with uncontrolled accumulation of progenitor cells susceptible to undergo genetic and epigenetic alterations and to initiate carcinogenic processes. 
LPC-MEDIATED DIFFERENTIATION THROUGH THE IL-27-WSX-1 AXIS
In addition to its function in triggering LPC activation in regenerating livers, we demonstrated that IL-17 also induced IL-27 cytokine production by macrophages. IL-27 is also described as an IFN-c-like cytokine that favors hematopoietic and neural precursor differentiation through signal transducer and activator of transcription 1 (41, 42) ; this is in addition to its proinflammatory (48) or anti-inflammatory (49) role according to the pathogenesis. Numerous studies revealed antitumor properties of IL-27 through the complex regulation of immune response, and this cytokine has also been reported to exert antiproliferative and anti-angiogenic effects by directly acting on cancer cells. (50) IL-27 has also been shown to directly favor cardiac progenitor cell differentiation, (37) expansion and differentiation of hematopoietic stem cells, (38, 39) and could support retinal progenitor cell differentiation. (36) In this model, we showed that disruption of IL-27 receptor signaling also prevented LPC accumulation. Alternatively, we showed a direct role of IL-27 on LPCs by favoring their differentiation into a hepatocytic phenotype in vitro without a direct mitogenic effect. Additional experiments, such as lineage tracing in several models, including CDE, or hepatocyte-specific MDM2 proto-oncogene (Mdm2)-deficient mice, are required to conclude on the role of IL-27 effects on LPC differentiation in vivo. (11) (12) (13) Reduced LPC accumulation in WSX-1 2/2 mice was associated with a significant decrease in recruitment of macrophages, which are reported as crucial actors in supporting LPC expansion. (44) We also showed a direct effect of IL-27 on promoting proinflammatory cytokine gene expressions in macrophages. These data suggest that IL-27 may indirectly enhance LPC proliferation through favoring macrophage activation and cytokine production.
Taken together, in this present work we provide evidence of a dual role of IL-17 in regenerating livers from progenitors. IL-17 not only targets LPCs and stimulates their proliferation but also promotes IL-27-induced expression from macrophages, which contribute to LPC differentiation into a hepatocytic phenotype. These data shed light on the fact that both proliferative and differentiating processes of LPCs are essential to achieve liver regeneration. Our data also suggest that lack of a differentiating process may lead to immature LPC accumulation that is susceptible to cell transformation into cancer cells.
